Total Intravenous Anesthesia (TIVA)/Sevoflurane Initiated Intravenous Anesthesia (SIIVA) in Pediatric Patients

ConditionExtubation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 9
SponsorWake Forest University Health Sciences

About this trial

Because Propofol is the primary "anesthetic agent," and inhalational agents remain in trace quantities at the end of the procedure Sevoflurane initiated intravenous anesthesia (SIIVA) or not present at all Total intravenous anesthesia (TIVA) it is likely that different criteria may be predictive of extubation success in these patients compared to inhalational anesthesia.

Eligibility criteria

Qualifiers

Pediatric patients <10 years of age

Undergoing elective or emergency surgery with planned airway instrumentation with an endotracheal tube (ETT)

Patients having general anesthesia with a planned SIIVA or TIVA technique

Patients with an end tidal agent concentration of Sevoflurane<0.1% at the time of emergence and extubation

Disqualifiers

History of home oxygen use or ventilator dependence

Patients with cyanotic congenital heart disease

Patients undergoing anesthesia for imaging procedures alone

Patients intended to be managed with supraglottic airway

Trial design

Treatments tested in this trial

  • Total intravenous anesthesia (TIVA)
  • Sevoflurane initiated intravenous anesthesia (SIIVA)

Treatment groups

600 Participants
are divided into 2 treatment groups